Clinical trial
Impact of Immunosuppression in Patients With Inflammatory Bowel Disease on Responsiveness to Influenza Vaccine
NCT00542776 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Immunosuppression in Patients With Inflammatory Bowel Disease on Responsiveness to Influenza Vaccine
- Lead sponsor
- Boston Children's Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2007
- Completion date
- February 29, 2008
- Enrollment
- 146 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
antibody titers, immunosuppressed or non-immunosuppressed, inflammatory bowel disease (ibd), influenza vaccine, seroprotective titers